louisiana glp-1 gastrointestinal obstruction law firm Lawyer glp-1 gastric intestinal obstruction attorney

Genetic variants in GLP1R, GIPR, and FTO pathways may influence how quickly a patient's metabolism adapts to dose escalation

Date: Wednesday, 10 April Time: Noon-1 PM ET In this live webinar, Patricia Davidson, DCN, RDN, LDN, CDCES, FAND, CHSE, FADCES, and Beth Czerwony, MS, RD, CSOWM, LD, will review the coexisting mechanisms between diabetes and obesity, and the necessary dietary interventions to complement and manage the side effects of GLP-1s and other medications

That means evaluating the patient, reviewing medical history, considering lab work, discussing realistic goals, and monitoring response over time

Patients start off going weekly for treatment for a few months

United State Food and Drug Administration